EP 1071450 A2 20010131 - COMBINATION OF ANTIGEN PULSED APCS AND INTERLEUKIN 12 FOR TUMOUR AND VIRAL THERAPY

Title (en)

COMBINATION OF ANTIGEN PULSED APCS AND INTERLEUKIN 12 FOR TUMOUR AND VIRAL THERAPY

Title (de)

KOMBINATION DER ANTIGEN-INKUBIERTEN APCS UND INTERLEUKIN 12 ZUR TUMOR- UND VIRALE THERAPIE

Title (fr)

ADJUVANTS FAISANT OFFICE DE VACCINS PERMETTANT L'IMMUNISATION CONTRE LES MELANOMES

Publication

EP 1071450 A2 20010131 (EN)

Application

EP 99921452 A 19990423

Priority

US 9908889 W 19990423
US 6496498 A 19980423
US 16883298 A 19981008

Abstract (en)

[origin: WO9953949A2] The invention provides methods of inducing the production of cytolytic T lymphocytes directed against malignancy or infectious agent by a mammal and treating such disease such that deleterious side effects are minimized and treatment of metastatic melanomas are surprisingly and dramatically improved.

IPC 1-7

A61K 39/00; A61K 39/12; A61K 39/39

IPC 8 full level

A61K 38/00 (2006.01); A61K 35/12 (2006.01); A61K 35/18 (2006.01); A61K 35/28 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 39/39 (2006.01); A61P 17/00 (2006.01); A61P 35/00 (2006.01)

CPC (source: EP US)

A61K 39/001156 (2018.08 - US); A61K 39/001186 (2018.08 - US); A61K 39/00119 (2018.08 - US); A61K 39/001191 (2018.08 - US); A61K 39/001192 (2018.08 - US); A61K 39/39 (2013.01 - EP); A61K 39/4615 (2023.05 - EP); A61K 39/4622 (2023.05 - EP); A61K 39/464486 (2023.05 - EP); A61K 39/46449 (2023.05 - EP); A61K 39/464491 (2023.05 - EP); A61P 17/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61K 2039/55538 (2013.01 - EP); A61K 2239/31 (2023.05 - EP); A61K 2239/57 (2023.05 - EP); Y02A 50/30 (2018.01 - EP)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9953949 A2 19991028; WO 9953949 A3 20000309; WO 9953949 A9 20000525; AU 3865999 A 19991108; AU 767208 B2 20031106; CA 2326406 A1 19991028; EP 1071450 A2 20010131; JP 2002512202 A 20020423; NZ 507829 A 20040326

DOCDB simple family (application)

US 9908889 W 19990423; AU 3865999 A 19990423; CA 2326406 A 19990423; EP 99921452 A 19990423; JP 2000544352 A 19990423; NZ 50782999 A 19990423